Home » Pharmaceuticals
Hospital Chain Tenet Acquires Vanguard Health
Tenet Healthcare, a US hospital operator, announced that it will acquire its rival Vanguard Health Systems for $1.73 billion. It would give it a better position to benefit from President Barack Obama’s healthcare reform. Investors... More of this article »
Healthcare Sector Leads Wall Street Increase
Stocks increased Tuesday, which was headed by the healthcare sector. The rally came after the government announced its decision on payment rates. Investors also felt optimistic after the release of the report on factory orders that... More of this article »
Justice Department Settles Online Pharmacy Probe with UPS
The U.S. Justice Department announced it had reached an agreement for $40 million Friday to settle charges against UPS that the giant shipping company had done business with Internet pharmacies that were illegal. U.S. officials agreed... More of this article »
Pharmaceuticals Give Large Sums of Money to Physicians
Most patients are unaware that different pharmaceutical companies give doctors thousands of dollars for each patient that they enrol in experimental drug trials. Even though the motive’s of the doctor’s may be pure and the medications... More of this article »
Profit at Merck Falls in Fourth Quarter
Merck, the pharmaceutical giant based in Whitehouse Station, New Jersey, announced that profits fell in the fourth quarter of 2012 by 7%. Company officials said that was due in part to sales of Singulair, its best selling asthma medication,... More of this article »
FDA Approves New Use for Pfizer Vaccine
Pfizer received approval from the U.S. Food and Drug Administration on Friday to use Prevnar 13 in children and adolescents between the age of 6 and 17 to prevent Invasive Pneumococcal Disease. Prevnar 13 becomes the first and just... More of this article »
Johnson & Johnson Diabetes Drug Gets Advisory Board Approval
On Thursday, a new drug being developed by Johnson & Johnson was given backing by an advisory panel that voted 10 to 5 in favor of recommending the drug to the U.S. Food and Drug Administration. If approved, the drug would be the... More of this article »
Anti-Clotting Drug Approved by FDA
Eliquis, the anti-clotting drug by Bristol-Myers Squibb and Pfizer was approved on Friday by the U.S. Food and Drug Administration. The FDA approval had been long anticipated by many cardiologists and is considered the next blockbuster... More of this article »
Draftfcb Healthcare Acquires Hudson Global, Retains Management Team
Interpublic Group (NYSE:IPG) subsidiary Draftfcb Healthcare announced today that they are acquiring N.Y.-based pharmaceutical marketing company Hudson Global which offers integrated marketing solutions aimed at the pharmaceutical industry. Hudson... More of this article »
Jazz Pharma (JAZZ) Wraps Up EUSA Pharma Acquisition
Jazz Pharmaceuticals (NASDAQ:JAZZ) has announced that they have wrapped up their acquisition of privately-held EUSA Pharma for $680 million in cash and notes it is accretive to their earnings and expect incremental modified EPS of... More of this article »
Omnicell (OMCL) Completes MTS Medication Tech Bid
Omnicell, Inc., (NASDAQ:OMCL) announced today it has completed its acquisition of MTS Medication Technologies, Inc., which the company had previously stated on May 2nd, 2012 that it intended to do. Randall Lipps, chairman, president... More of this article »
OriGene Technologies Acquires Beijing Zhongshan Golden Bridge Biotechnology
OriGene Technologies, Inc. announced today the acquisition of Beijing Zhongshan Golden Bridge Biotechnology Co., Ltd (ZsBio). Founded in the year 1993, ZsBio provides testing products (pathology) within their domestic Chinese market,... More of this article »
Abbott Laboratories (ABT) Announces Initiation of ESPRIT I
Abbott Laboratories (NYSE:ABT) announced today that they are initiating ESPRIT I which the company says is a first-of-its-kind clinical trial in Europe. The trial is for performance evaluation of Esprit. The drug itself is a bioresorbable... More of this article »
IDEXX Labs Acquires RADIL Reference Laboratory
IDEXX Laboratories, Inc. (NASDAQ:IDXX) announced today that it has acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. IDEXX paid the the University... More of this article »
AstraZeneca Launches $200 Million Dollar Facility in China
AstraZeneca announced today that they have upped their investment stake in China with the launch of a $200 million dollar manufacturing facility in the country. The new plant will be in China Medical City (or, CMC), Taizhou, Jiangsu... More of this article »
Merck Gets $175 Million from J&J Joint Venture Sale
Merck announced today that they are removing themselves from participation in a joint venture called “Johnson & Johnson Merck Consumer Pharmaceuticals.” Merck had a 50% interest in the venture with Johnson & Johnson... More of this article »
AstraZeneca’s FASLODEX Receives First Approval in Japan
AstraZeneca announced today that their FASLODEX 500mg product received its first regulatory approval in Japan. FASLODEX 500mg is a breast cancer drug which had already gained regulatory approval in Europe in March, 2010 and in the... More of this article »
Bristol-Myers & Ambrx Announce Exclusive Research Rights Deal
Bristol-Myers Squibb & Ambrx, Inc. released a joint statement today which detailed a partnership where Bristol-Myers will gain exclusive worldwide rights to some of Ambrx’s research. In the agreement, Bristol-Myers will research,... More of this article »
GlaxoSmithKline & Amicus Begin Second Phase 3 Study of Amigal
GlaxoSmithKline (GSK) announced today that they and Amicus Therapeutics have began the second phase III study of Amigal by way of dosing in a global registration study (Study 012) in an effort to compare safety and efficacy of Amigal... More of this article »
Bristol-Myers Squibb Finalizes Acquisition of Amira Pharmaceuticals
The Bristol-Myers Squibb Company formally finalizes the acquisition of Amira Pharmaceuticals today. Amira Pharmaceuticals, Inc. had been a privately held company leading up to BMS’s acquisition of the company. Amira is noted... More of this article »
Abbott’s on Dow Jones Sustainability Indexes for Seventh Consecutive Year
Abbott has announced they have been included on not only the Dow Jones Sustainability World Index (DJSI) but also the North American index for seven consecutive years. The DJSI is a market benchmark for the performance of companies... More of this article »